Jesper Johannesen

Suppressor of cytokine signaling 3 (SOCS-3) protects β-cells against interleukin-1β- and interferon-γ-mediated toxicity

Allan E. Karlsen, Sif G. Rønn, Karen Lindberg et al. · Proceedings of the National Academy of Sciences · 2001 · 141 citations · Full text

Immune Regulation, Immunology, Cell Death +17

The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes

Birthe Susanne Olsen, Anne Katrin Sjølie, Philip Hougaard et al. · Journal of Diabetes and its Complications · 2004 · 115 citations

Type 1, Diabetic Retinopathy, Diabetes Management +7

A 6-year nationwide cohort study of glycaemic control in young people with Type 1 diabetes

Birthe Sussane Olsen, Anne-Katrin Sjølie, Philip Hougaard et al. · Journal of Diabetes and its Complications · 2000 · 102 citations

Metabolic Syndrome, Type 1, Young People +9

Residual β-Cell Function 3–6 Years After Onset of Type 1 Diabetes Reduces Risk of Severe Hypoglycemia in Children and Adolescents

Jesper Sørensen, Jesper Johannesen, Flemming Pociot et al. · Diabetes Care · 2013 · 87 citations · Full text

Heat shock protein induction in rat pancreatic islets by recombinant human interleukin 1?

Steffen Helqvist, Barbara S. Polla, Jesper Johannesen et al. · Diabetologia · 1991 · 85 citations · Full text

Inflammation, Cytokine, Islet Transplantation +10